CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways
Jiawei He(Xiamen University), Zhanxiang Wang(First Affiliated Hospital of Xiamen University), Jianyao Mao(Xiamen University), Yun‐wu Zhang(Yantai University), Hanwen Lu(Xiamen University), Wanhong Han(First Affiliated Hospital of Xiamen University), Wenhua Li(University of Hong Kong), Liang Zhang(Northeast Electric Power University), Xīn Gào(Qingdao University), Wentao Zhao(Xiamen University), Jian Meng(Xiamen University), Bingchang Zhang(First Affiliated Hospital of Xiamen University), Wenpeng Zhao(First Affiliated Hospital of Xiamen University), Hao Xu(Pudong Medical Center), Zhangyu Li(First Affiliated Hospital of Xiamen University), Guowei Tan(Xiamen University), Ziqian Tang(Xiamen University), Ping Zhong(First Affiliated Hospital of Xiamen University), Bosen Liu(Xiamen University), Sifang Chen(First Affiliated Hospital of Xiamen University), Chengtian Gao(Xiamen University), Zhe Shen(Université Paris Cité)
Cited by 3
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
APP processing in Alzheimer's disease
|Molecular Brain|2011|951
Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling
|The Journal of Cell Biology|2009|406
Regulatory Role of G Protein–Coupled Estrogen Receptor for Vascular Function and Obesity
|Circulation Research|2009|366